Arthromeda Overview
- Year Founded
-
2011

- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.44M
- Investors
-
1
Arthromeda General Information
Description
Developer of patient-specific medical technologies designed to offer cost-effective outcomes for improved arthroplasty surgery. The company's technologies utilize micro-sensors, wireless systems, and custom software applications to reduce operating room time, improve patient outcomes, and reduce the cost burden associated with early implant failure, enabling surgeons to minimize implant failure and revision rates.
Contact Information
Website
www.arthromeda.comCorporate Office
- 172 Middle Street
- Suite 207
- Lowell, MA 01852
- United States
Corporate Office
- 172 Middle Street
- Suite 207
- Lowell, MA 01852
- United States
Arthromeda Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Later Stage VC | 04-Feb-2025 | $2.44M | Completed | Generating Revenue | ||
6. Later Stage VC (Series F) | 06-Jan-2020 | Completed | Generating Revenue | |||
5. Later Stage VC (Series E) | 29-Jun-2018 | Completed | Generating Revenue | |||
4. Later Stage VC (Series D) | 01-Jun-2017 | Completed | Generating Revenue | |||
3. Later Stage VC (Series C) | 24-Mar-2016 | Completed | Startup | |||
2. Early Stage VC (Series B) | 06-Jan-2014 | $1.64M | $2.42M | Completed | Startup | |
1. Early Stage VC (Series A) | 11-Jan-2013 | $775K | $775K | Completed | Startup |
Arthromeda Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series E | ||||||||
Series D | ||||||||
Series C | ||||||||
Series B | 3,530,971 | $0.000100 | 6% | $0.68 | $0.68 | 1x | $0.68 | 22.07% |
Series A | 1,301,961 | $0.000100 | 6% | $0.6 | $0.6 | 1x | $0.6 | 8.14% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Arthromeda Patents
Arthromeda Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2017264879-A1 | Patient-specific prosthesis alignment | Inactive | 11-May-2016 | ||
EP-3454729-A1 | Patient-specific prosthesis alignment | Inactive | 11-May-2016 | ||
US-20170325892-A1 | Patient-specific prosthesis alignment | Inactive | 11-May-2016 | ||
EP-3454729-A4 | Patient-specific prosthesis alignment | Inactive | 11-May-2016 | ||
US-20200163721-A1 | Patient-specific prosthesis alignment | Inactive | 11-May-2016 | A61B34/10 |
Arthromeda Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Thornapple River Capital | Venture Capital | Minority |
Arthromeda FAQs
-
When was Arthromeda founded?
Arthromeda was founded in 2011.
-
Where is Arthromeda headquartered?
Arthromeda is headquartered in Lowell, MA.
-
What industry is Arthromeda in?
Arthromeda’s primary industry is Outcome Management (Healthcare).
-
Is Arthromeda a private or public company?
Arthromeda is a Private company.
-
What is Arthromeda’s current revenue?
The current revenue for Arthromeda is
. -
How much funding has Arthromeda raised over time?
Arthromeda has raised $11.3M.
-
Who are Arthromeda’s investors?
Thornapple River Capital has invested in Arthromeda.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »